{{Rsnum
|rsid=7629490
|Chromosome=3
|position=87192347
|Orientation=plus
|GMAF=0.3411
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 45.5 | 42.9 | 11.6
| HCB | 37.2 | 44.5 | 18.2
| JPT | 25.9 | 57.1 | 17.0
| YRI | 66.0 | 31.3 | 2.7
| ASW | 53.6 | 39.3 | 7.1
| CHB | 37.2 | 44.5 | 18.2
| CHD | 49.1 | 37.0 | 13.9
| GIH | 39.6 | 50.5 | 9.9
| LWK | 56.4 | 35.5 | 8.2
| MEX | 36.2 | 41.4 | 22.4
| MKK | 57.4 | 35.5 | 7.1
| TSI | 44.6 | 47.5 | 7.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21743057
|Trait=None
|Title=Genome-wide association study identifies new prostate cancer susceptibility loci.
|RiskAllele=T
|Pval=1E-7
|OR=1.0600
|ORtxt=[1.04-1.09]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}